11:15–11:45

Detection and Response Activities of Vaccine Manufacturers

Luc Hessel, Pasteur Mérieux Connaught

Robert Levine, Lederle-Praxis Biologicals

Robert Sharrar, Merck Research Laboratories

11:45–12:15 p.m.

Experiences of Consumers with Adverse Event Detection and Response

Barbara Loe Fisher, National Vaccine Information Center

Mark Geier, Medical/Legal Consultant

Kathy Schaus, Little Rock, Arkansas

Jack Sexton, Woodbridge, Virginia

12:15–1:15

LUNCH

IV. Examples of Methodologies Applied to Research on Vaccine Adverse Events

1:15–1:30

Vaccine Lot Surveillance

Susan Ellenberg, Food and Drug Administration

1:30–1:45

Reviewing Case Reports

Frederick Varricchio, Food and Drug Administration

1:45–2:00

Analysis of Seizure Reports in LLDBs

Robert Davis, Group Health Cooperative, Seattle

2:00–2:15

Studying Immune-mediated Disorders

John Martin, University of Southern California School of Medicine

2:15–2:30

BREAK

V. Panel Discussions

2:30–3:15

Panel 1—Reporting and Data Collection

Moderator: Linda Cowan, University of Oklahoma Health Sciences Center

Panelists: Barbara Loe Fisher, National Vaccine



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement